Loading...
 
210 6545243
 

Πρόσφατες δημοσιεύσεις για ρευματικά νοσήματα και COVID-19

 

EULAR View-points on SARS-CoV-2 vaccination in patients with RMDs

https://www.eular.org/eular_sars_cov_2_vaccination_rmd_patients.cfm

 


Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases

https://ard.bmj.com/content/early/2021/11/10/annrheumdis-2021-221539

https://ard.bmj.com/content/annrheumdis/early/2021/11/10/annrheumdis-2021-221539.full.pdf

Ann Rheum Dis: first published as 10.1136/annrheumdis-2021-221539 on 10 November 2021


Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

https://ard.bmj.com/content/early/2021/03/24/annrheumdis-2021-220272

https://ard.bmj.com/content/annrheumdis/early/2021/03/24/annrheumdis-2021-220272.full.pdf

Ann Rheum Dis 2021;0:1–6. doi:10.1136/annrheumdis-2021-220272


Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience

https://link.springer.com/content/pdf/10.1007/s00296-021-04818-2.pdf 

Rheumatol Int. 2021 Mar 3;1-7. doi: 10.1007/s00296-021-04818-2. Online ahead of print.


Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

https://ard.bmj.com/content/early/2021/01/26/annrheumdis-2020-219498

https://ard.bmj.com/content/annrheumdis/early/2021/01/26/annrheumdis-2020-219498.full.pdf

Ann Rheum Dis. 2021 Jan 27; annrheumdis-2020-219498. doi: 10.1136/annrheumdis-2020-219498. Online ahead of print.


Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

https://ard.bmj.com/content/early/2021/02/22/annrheumdis-2021-219845

https://ard.bmj.com/content/annrheumdis/early/2021/02/22/annrheumdis-2021-219845.full.pdf?with-ds=yes

Ann Rheum Dis. 2021 Feb 23;annrheumdis-2021-219845. doi: 10.1136/annrheumdis-2021-219845. Online ahead of print


Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

https://ard.bmj.com/content/early/2020/12/01/annrheumdis-2020-218310?utm_source=alert&utm_medium=email&utm_campaign=ard&utm_content=latest&utm_term=05122020

https://ard.bmj.com/content/annrheumdis/early/2020/12/01/annrheumdis-2020-218310.full.pdf

Ann Rheum Dis. 2020 Dec 2;annrheumdis-2020-218310.  doi: 10.1136/annrheumdis-2020-218310. Online ahead of print


Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic

https://ard.bmj.com/content/early/2020/11/29/annrheumdis-2020-219279?utm_source=alert&utm_medium=email&utm_campaign=ard&utm_content=latest&utm_term=05122020

https://ard.bmj.com/content/annrheumdis/early/2020/11/29/annrheumdis-2020-219279.full.pdf

Ann Rheum Dis. 2020 Nov 30:annrheumdis-2020-219279. doi: 10.1136/annrheumdis-2020-219279. Online ahead of print


Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

https://www.nejm.org/doi/full/10.1056/NEJMoa2023184

https://www.nejm.org/doi/pdf/10.1056/NEJMoa2023184?articleTools=true


Non‐steroidal anti‐inflammatory drugs and susceptibility to COVID‐19

https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41593?campaign=wolacceptedarticle

https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41593

Arthritis Rheumatol. 2020 Nov 13. doi: 10.1002/art.41593. Online ahead of print.


Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

https://onlinelibrary.wiley.com/doi/full/10.1002/art.41425?campaign=wolearlyview

https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41425

Arthritis Rheumatol. 2020 Jun 30:10.1002/art.41425. doi: 10.1002/art.41425. Online ahead of print.

 


Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis


Ann Rheum Dis. 2020 Oct 13;annrheumdis-2020-218946. doi: 10.1136/annrheumdis-2020-218946. Online ahead of print


Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30305-2/fulltext

https://www.thelancet.com/action/showPdf?pii=S2665-9913%2820%2930305-2

Lancet Rheumatol. 2020 Sep 21. doi: 10.1016/S2665-9913(20)30305-2. Online ahead of print.


Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients with Systemic Lupus Erythematosus

https://onlinelibrary.wiley.com/doi/10.1002/art.41450

https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41450

Arthritis Rheumatol.2020 Jul 26. doi: 10.1002/art.41450. Online ahead of print.


Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐analysis

https://onlinelibrary.wiley.com/doi/10.1002/art.41469

https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41469

Putman M, et al. Arthritis Rheumatol. 2020. PMID: 32741139


Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays

https://www.sciencedirect.com/science/article/pii/S1472648320303187?via%3Dihub

https://www.rbmojournal.com/article/S1472-6483(20)30318-7/fulltext

 


Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

https://ard.bmj.com/content/79/9/1143?utm_source=alert&utm_medium=email&utm_campaign=ard&utm_content=latest&utm_term=07082020

https://ard.bmj.com/content/annrheumdis/79/9/1143.full.pdf

Ramiro S, et al. Ann Rheum Dis. 2020. PMID: 32719045


Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

https://ard.bmj.com/content/early/2020/08/12/annrheumdis-2020-218296?utm_source=alert&utm_medium=email&utm_campaign=ard&utm_content=latest&utm_term=15082020

https://ard.bmj.com/content/annrheumdis/early/2020/08/12/annrheumdis-2020-218296.full.pdf

Ann Rheum Dis.2020 Aug 12;annrheumdis-2020-218296. doi: 10.1136/annrheumdis-2020-218296. Online ahead of print.


COVID‐19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes

https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41456?campaign=wolacceptedarticle

https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41456

Arthritis Rheumatol.2020 Jul 28. doi: 10.1002/art.41456. Online ahead of print.

 


Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

https://www.nature.com/articles/s41591-020-0965-6

https://www.nature.com/articles/s41591-020-0965-6.pdf

Nat Med.2020 Jun 18.doi: 10.1038/s41591-020-0965-6.Online ahead of print


Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?

https://ard.bmj.com/content/early/2020/07/08/annrheumdis-2020-218259?utm_source=alert&utm_medium=email&utm_campaign=ard&utm_content=latest&utm_term=14072020

https://ard.bmj.com/content/annrheumdis/early/2020/07/08/annrheumdis-2020-218259.full.pdf

Ann Rheum Dis. 2020 Jul 9;annrheumdis-2020-218259. doi: 10.1136/annrheumdis-2020-218259. Online ahead of print.


Tocilizumab for treatment of mechanically ventilated patients with COVID-19

https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa954/5870306

 


Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases

https://ard.bmj.com/content/early/2020/06/30/annrheumdis-2020-218054?utm_source=alert&utm_medium=email&utm_campaign=ard&utm_content=latest&utm_term=06072020

https://ard.bmj.com/content/annrheumdis/early/2020/06/30/annrheumdis-2020-218054.full.pdf

Ann Rheum Dis. 2020 Jun 30;annrheumdis-2020-218054. doi: 10.1136/annrheumdis-2020-218054. Online ahead of print


Brief Report: Anti‐phospholipid antibodies in critically ill patients with Coronavirus Disease 2019 (COVID‐19)

https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41425?campaign=wolacceptedarticle

https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41425

Arthritis Rheumatol. 2020 Jun 30. doi: 10.1002/art.41425. Online ahead of print.


Anti‐cardiolipin IgG autoantibodies are an independent risk factor of COVID‐19 severity

https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41409?campaign=wolacceptedarticle

https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41409

Arthritis Rheumatol. 2020 Jun 21;10.1002/art.41409. doi: 10.1002/art.41409. Online ahead of print.


Tocilizumab for treatment of patients with severe COVID–19: A retrospective cohort study

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30162-0/fulltext

https://www.thelancet.com/action/showPdf?pii=S2589-5370%2820%2930162-0

 


Perspectives of patients with rheumatic diseases in the early phase of COVID‐19

https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.24347?campaign=wolacceptedarticle

https://onlinelibrary.wiley.com/doi/epdf/10.1002/acr.24347

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

https://ard.bmj.com/content/early/2020/06/11/annrheumdis-2020-217960

https://ard.bmj.com/content/annrheumdis/early/2020/06/11/annrheumdis-2020-217960.full.pdf

Ann Rheum Dis. 2020 Jun 11;annrheumdis-2020-217960. doi: 10.1136/annrheumdis-2020-217960. Online ahead of print.


Anakinra for severe forms of COVID-19: a cohort study

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30164-8/fulltext

https://www.thelancet.com/action/showPdf?pii=S2665-9913%2820%2930164-8

Published:May 29, 2020DOI:https://doi.org/10.1016/S2665-9913(20)30164-8


A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

https://www.nejm.org/doi/full/10.1056/NEJMoa2016638

https://www.nejm.org/doi/pdf/10.1056/NEJMoa2016638?articleTools=true

PMID: 32492293 DOI: 10.1056/NEJMoa2016638


COVID-19 and systemic lupus erythematosus: a case series

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30161-2/fulltext

https://www.thelancet.com/action/showPdf?pii=S2665-9913%2820%2930161-2

Published Online May 26, 2020 https://doi.org/10.1016/ S2665-9913(20)30161-2


Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARSCoV-2 infection and severe COVID-19

https://ard.bmj.com/content/early/2020/05/20/annrheumdis-2020-217690

https://ard.bmj.com/content/annrheumdis/early/2020/05/20/annrheumdis-2020-217690.full.pdf

PMID: 32381561 DOI: 10.1136/annrheumdis-2020-217690


Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

https://ard.bmj.com/content/early/2020/05/29/annrheumdis-2020-217871

https://ard.bmj.com/content/annrheumdis/early/2020/05/29/annrheumdis-2020-217871.full.pdf

Ann Rheum Dis. 2020 May 29;annrheumdis-2020-217871. doi: 10.1136/annrheumdis-2020-217871. Online ahead of print


Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic

https://ard.bmj.com/content/annrheumdis/early/2020/05/31/annrheumdis-2020-217935.full.pdf

Ann Rheum Dis. 2020 May 31;annrheumdis-2020-217935. doi: 10.1136/annrheumdis-2020-217935. Online ahead of print


Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China

https://ard.bmj.com/content/early/2020/05/22/annrheumdis-2020-217627

https://ard.bmj.com/content/annrheumdis/early/2020/05/22/annrheumdis-2020-217627.full.pdf

Ann Rheum Dis: 2020 May 22;annrheumdis-2020-217627. doi: 10.1136/annrheumdis-2020-217627. Online ahead of print.


Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30127-2/fulltext

www.thelancet.com/rheumatology. Published online May 7, 2020 https://doi.org/10.1016/S2665-9913(20)30127-2


Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19

https://www.nejm.org/doi/full/10.1056/NEJMc2013656

May 5, 2020 DOI: 10.1056/NEJMc2013656


Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

https://www.nejm.org/doi/full/10.1056/NEJMc2007575

N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.


Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York

https://www.nejm.org/doi/full/10.1056/NEJMc2009567?query=featured_home

N Engl J Med. 2020 Apr 29. doi: 10.1056/NEJMc2009567. [Epub ahead of print]


Effective treatment of severe COVID-19 patients with tocilizumab

https://www.pnas.org/content/pnas/early/2020/04/27/2005615117.full.pdf

PNAS first published April 29, 2020 https://doi.org/10.1073/pnas.2005615117


Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis

http://www.jrheum.org/content/jrheum/early/2020/04/24/jrheum.200507.full.pdf

J Rheumatol. 2020 Apr 25. pii: jrheum.200507. doi: 10.3899/jrheum.200507. [Epub ahead of print]


Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies 

https://ard.bmj.com/content/79/5/667.long

Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2.


Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine 

https://ard.bmj.com/content/early/2020/04/24/annrheumdis-2020-217566

Ann Rheum Dis. 2020 Apr 24. pii: annrheumdis-2020-217566. doi: 10.1136/annrheumdis-2020-217566. [Epub ahead of print]


Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. 

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30095-3/fulltext 

Lancet Rheumatol. 2020 Apr 16. doi: 10.1016/S2665-9913(20)30095-3. [Epub ahead of print]


Recomendations Regarding COVID-19 Infection in Rheumatic Patients in Greece

https://mjrheum.org/current-issue/newsid792/204, Published 31 Mar 2020

Mediterr J Rheumatol 2020;31(1):6-7

 

Επιστημονική Ενημέρωση

Σημαντικό επιστημονικό υλικό για την συνεχή εκπαίδευση και ενημέρωση των επιστημόνων υγείας.

Επιστημονικό Υλικό

Σημαντικό επιστημονικό υλικό, webinars, παρουσιάσεις, video, κείμενα συνεχιζόμενης ρευματολογικής εκπαίδευσης.

Συνεχιζόμενη Εκπαίδευση

Δείτε αναλυτικά τις Επιστημονικές Εκδηλώσεις και τα Συνέδρια της ΕΡΕ-ΕΠΕΡΕ.

Εξελίξεις στη Ρευματολογία

Επιλογή από πρόσφατες δημοσιεύσεις της διεθνούς βιβλιογραφίας.

Πρόσβαση στα διεθνή περιοδικά

Η Ελληνική Ρευματολογική Εταιρία, στα πλαίσια των υπηρεσιών που προσφέρει στα μέλη της, εξασφαλίζει την πρόσβαση σε ηλεκτρονικά περιοδικά που σχετίζονται με την Ρευματολογία.

Developed by LogicOne